NAS:RARX (USA) Also Trade In: Germany

Ra Pharmaceuticals Inc $ 47.99 0 (0%)

Volume:
0
Avg Vol (1m):
0
Market Cap $:
2.27 Bil
Enterprise Value $:
2.01 Bil
P/E (TTM):
0.00
P/B:
8.65
Warning! GuruFocus has detected 2 Severe warning signs with RARX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for RARX (Ra Pharmaceuticals Inc) from 2016 to Oct 27 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Ra Pharmaceuticals stock (RARX) PE ratio as of Oct 27 2020 is 0. More Details

Ra Pharmaceuticals PE Ratio (TTM) Chart

EMBED

Ra Pharmaceuticals PE Ratio (TTM) Historical Data

Total 895
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10
Ra Pharmaceuticals PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-10-270.0 2020-02-050.0
2020-04-070.0 2020-02-040.0
2020-04-060.0 2020-02-030.0
2020-04-030.0 2020-01-310.0
2020-04-020.0 2020-01-300.0
2020-04-010.0 2020-01-290.0
2020-03-310.0 2020-01-280.0
2020-03-300.0 2020-01-270.0
2020-03-270.0 2020-01-240.0
2020-03-260.0 2020-01-230.0
2020-03-250.0 2020-01-220.0
2020-03-240.0 2020-01-210.0
2020-03-230.0 2020-01-200.0
2020-03-200.0 2020-01-170.0
2020-03-190.0 2020-01-160.0
2020-03-180.0 2020-01-150.0
2020-03-170.0 2020-01-140.0
2020-03-160.0 2020-01-130.0
2020-03-130.0 2020-01-100.0
2020-03-120.0 2020-01-090.0
2020-03-110.0 2020-01-080.0
2020-03-100.0 2020-01-070.0
2020-03-090.0 2020-01-060.0
2020-03-060.0 2020-01-030.0
2020-03-050.0 2020-01-020.0
2020-03-040.0 2020-01-010.0
2020-03-030.0 2019-12-310.0
2020-03-020.0 2019-12-300.0
2020-02-280.0 2019-12-270.0
2020-02-270.0 2019-12-260.0
2020-02-260.0 2019-12-240.0
2020-02-250.0 2019-12-230.0
2020-02-240.0 2019-12-200.0
2020-02-210.0 2019-12-190.0
2020-02-200.0 2019-12-180.0
2020-02-190.0 2019-12-170.0
2020-02-180.0 2019-12-160.0
2020-02-170.0 2019-12-130.0
2020-02-140.0 2019-12-120.0
2020-02-130.0 2019-12-110.0
2020-02-120.0 2019-12-100.0
2020-02-110.0 2019-12-090.0
2020-02-100.0 2019-12-060.0
2020-02-070.0 2019-12-050.0
2020-02-060.0 2019-12-040.0

Ra Pharmaceuticals PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » NAICS : 325412 NAICS : 2834
Traded in other countries P61.Germany RARX.USA
Address 87 Cambridge Park Drive, Cambridge, MA, USA, 02140
Ra Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers and develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Geographically business of the firm can be seen amplifying in the United States, Europe and even at international level.